✦ LIBER ✦

German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs

✍ Scribed by Albrecht, Katinka; Krüger, Klaus; Wollenhaupt, Jürgen; Alten, Rieke; Backhaus, Marina; Baerwald, Christoph; Bolten, Wolfgang; Braun, Jürgen; Burkhardt, Harald; Burmester, Gerd R.; Gaubitz, Markus; Gause, Angela; Gromnica-Ihle, Erika; Kellner, Herbert; Kuipers, Jens; Krause, Andreas; Lorenz, Hans-Martin; Manger, Bernhard; Nüßlein, Hubert; Pott, Hans-Georg; Rubbert-Roth, Andrea; Schneider, Matthias; Specker, Christof; Schulze-Koops, Hendrik; Tony, Hans-Peter; Wassenberg, Siegfried; Müller-Ladner, Ulf

Book ID: 121581054
Publisher: Springer
Year: 2013
Tongue: English
Weight: 262 KB
Volume: 34
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-013-2848-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mixed Treatment Comparison of the Treatm

Mixed Treatment Comparison of the Treatment Discontinuations of Biologic Disease-Modifying Antirheumatic Drugs in Adults with Rheumatoid Arthritis

✍ Desai, R. J.; Hansen, R. A.; Rao, J. K.; Wilkins, T. M.; Harden, E. A.; Yuen, A. 📂 Article 📅 2012 🏛 Harvey Whitney Books Company 🌐 English ⚖ 388 KB

Approaches to the treatment of early rhe

Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs

✍ Lyudmila Sizova 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

Renal toxicity associated with disease-m

Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis

✍ Michael H. Schiff; Andrew Whelton 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Guidelines for the Use of Conventional a

Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis

✍ Dr Alejandro Díaz-Borjón 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 244 KB

Premise: traditional disease-modifying a

Premise: traditional disease-modifying antirheumatic drugs are less effective and safe than targeted therapy with biologic response modifiers in rheumatoid arthritis

✍ R Fleischmann 📂 Article 📅 2003 🏛 BioMed Central 🌐 English ⚖ 554 KB

EULAR recommendations for the management

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

✍ Smolen, J. S.; Landewe, R.; Breedveld, F. C.; Dougados, M.; Emery, P.; Gaujoux-V 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 305 KB